Atea Announces Update on Collaboration with Roche for AT-527

TOKYO, November 17, 2021 -- Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) announced that Atea issued a press release on its collaboration with Roche for the investigational oral COVID-19 treatment AT-527. Please refer to the link below for details: Atea Pharmaceuticals Provides Update on Strategic Collaboration with Roche https://ir.ateapharma.com/news-releases/news-release-details/atea-pharmaceuticals-provides-update-strategic-collaboration

The release as fetched from its publisher. chugai-pharm.co.jp ↗